跳转至内容
Merck
CN
  • Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome.

Journal of lipid research (2014-10-25)
Fabiana Rached, Raul D Santos, Laurent Camont, Marcio H Miname, Marie Lhomme, Carolane Dauteuille, Sora Lecocq, Carlos V Serrano, M John Chapman, Anatol Kontush
摘要

To evaluate functional and compositional properties of HDL in subjects from a kindred of genetic apoA-I deficiency, two homozygotes and six heterozygotes, with a nonsense mutation at APOA1 codon -2, Q[-2]X, were recruited together with age- and sex-matched healthy controls (n = 11). Homozygotes displayed undetectable plasma levels of apoA-I and reduced levels of HDL-cholesterol (HDL-C) and apoC-III (5.4% and 42.6% of controls, respectively). Heterozygotes displayed low HDL-C (21 ± 9 mg/dl), low apoA-I (79 ± 24 mg/dl), normal LDL-cholesterol (132 ± 25 mg/dl), and elevated TG (130 ± 45 mg/dl) levels. Cholesterol efflux capacity of ultracentrifugally isolated HDL subpopulations was reduced (up to -25%, P < 0.01, on a glycerophospholipid [GP] basis) in heterozygotes versus controls. Small, dense HDL3 and total HDL from heterozygotes exhibited diminished antioxidative activity (up to -48%, P < 0.001 on a total mass basis) versus controls. HDL subpopulations from both homozygotes and heterozygotes displayed altered chemical composition, with depletion in apoA-I, GP, and cholesteryl ester; enrichment in apoA-II, free cholesterol, and TG; and altered phosphosphingolipidome. The defective atheroprotective activities of HDL were correlated with altered lipid and apo composition. These data reveal that atheroprotective activities of HDL particles are impaired in homozygous and heterozygous apoA-I deficiency and are intimately related to marked alterations in protein and lipid composition.

材料
产品编号
品牌
产品描述

Supelco
甲酸铵, eluent additive for LC-MS, LiChropur, ≥99.0%
Sigma-Aldrich
甲酸铵, reagent grade, 97%
Sigma-Aldrich
甲酸铵, ≥99.995% trace metals basis
Sigma-Aldrich
甲酸铵 溶液, BioUltra, 10 M in H2O
Sigma-Aldrich
L-丝氨酸, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-丝氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
O-磷酸乙醇胺
Sigma-Aldrich
甲酸铵, BioUltra, ≥99.0% (calc. based on dry substance, NT)
Sigma-Aldrich
1,2-二硬脂酰--甘油基-3-磷酸胆碱, ≥99%
Sigma-Aldrich
甲酸, ≥95%, FCC, FG
Sigma-Aldrich
1,2-二棕榈酰-sn-甘油-3-磷酰胆碱, ≥99% (TLC)
Sigma-Aldrich
1,2-二棕榈酰-sn-甘油-3-磷酰胆碱, semisynthetic, ≥99%
Sigma-Aldrich
2-油酰-1-棕榈酰--甘油基-3-磷酸胆碱, ≥99.0% (TLC)
Sigma-Aldrich
L-丝氨酸, BioUltra, ≥99.5% (NT)
Supelco
甲酸铵 溶液, 10 mM in H2O, suitable for HPLC
Sigma-Aldrich
1,2-二肉豆蔻酰基-sn-甘油-3-磷酸胆碱, ≥99%
Supelco
L-丝氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
甲酸 溶液, BioUltra, 1.0 M in H2O
Sigma-Aldrich
2-油酰-1-棕榈酰--甘油基-3-磷酸胆碱, ≥95.5% (GC), ≥98% (TLC)
Supelco
L-丝氨酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland